Gifu Pharmaceutical University · Major Course in Practical Pharmacy · 教授

Research keywordsdrug development, regulation, benefit-risk analysis

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Industry Perspective of Pediatric Drug Development in the United States
• Safety-Related Regulatory Actions and Risk Factors for Anticancer Drugs in Japan.
• Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies
• Improvement of Pediatric Drug Development: Regulatory and Practical Frameworks.

• 規制当局の医薬品製造販売許認可の判断に関する分析 To analyze regulatory bodies' decision for the authorization of drugs and medical devices 規制当局の論理構造に関する分析 To analyze regulatory bodies' theoretical framework 製薬企業における臨床開発や薬事戦略の分析 To analyze pharmaceutical companies' clinical development and pharmaceutical affairs strategies 規制当局内部門間の判断基準比較研究 To investigate the comparative evaluation criteria between divisions in regulatory bodies シーズ Research Topics より良い医薬品で社会貢献 情報学との融合で薬学は新たなステージへ
• ワクチンの新規ベネフィット・リスク分析法による政策評価に関する研究

• Official profile